The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC).
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Ferring; Janssen Research & Development; Merck; Onclive; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group
Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Asterias Biotherapeutics; Ferring; Onclive; Physicans' Education Resource; WIRB-Copernicus Group
 
Ryon P Graf
Employment - Epic Sciences
Research Funding - Epic Sciences
Travel, Accommodations, Expenses - Epic Sciences
 
Nicole A. Schreiber
No Relationships to Disclose
 
Eric Winquist
Honoraria - Merck
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis (Inst); Medivation (Inst); Oncogenex (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Brigit McLaughlin
No Relationships to Disclose
 
David Lu
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Sarah Orr
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Martin Fleisher
No Relationships to Disclose
 
Lori Lowes
No Relationships to Disclose
 
Amanda K. L. Anderson
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Yipeng Wang
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Ryan Vance Dittamore
Employment - Epic Sciences
Leadership - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Patents, Royalties, Other Intellectual Property - Patents Pending
 
Alison L Allan
No Relationships to Disclose
 
Gerhardt Attard
Honoraria - Astellas Pharma; Janssen
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; Bayer; ESSA; Janssen-Cilag; Medivation; Millennium; Novartis; Ventana Medical Systems; Veridex
Speakers' Bureau - Astellas Pharma; Janssen; Sanofi; Takeda; Ventana Medical Systems
Research Funding - Arno Therapeutics (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.
Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Janssen; Janssen (I); Medivation; Ventana Medical Systems
Other Relationship - Institute of Cancer Research
 
Glenn Heller
Research Funding - Janssen Diagnostics